EcoR1 Capital, LLC

Q3 2026 13F-HR Holdings

Location
San Francisco, CA
Holdings as of
9/30/2026
Date filed
11/16/2026
Form type
13F-HR
Num holdings
36
Total value ($000)
$2,252,571
Net value change ($000)
+195,838 (9.5%)
New positions
9
Sold out positions
5
Turnover %
11.6%
Sector allocation + QoQ delta (equities-only)

Snapshot: Change Analysis

Compared to Q2 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
ANRO 56,983 NEW
FIRST TRACKS BIOTHERAPEUTICS 48,634 76.1%
ETON 48,604 61.8%
ERAS 37,201 615.3%
ATTOVIA THERAPEUTICS INC 34,692 NEW
CGON 26,528 25.0%
ADARX PHARMACEUTICALS INC 22,931 NEW
ELECTRA THERAPEUTICS INC 19,125 NEW
CAPR 13,036 NEW
XNCR 12,475 NEW
Top Reduces (Value $000, Stocks/ETFs)
ANAB -135,852 -25.5%
AKTS -61,561 -39.6%
ORIC -32,076 -44.0%
LEGN -23,104 -100.0%
MBX -21,445 -100.0%
BBOT -17,865 -83.0%
RLAY -13,059 -100.0%
PHAT -6,781 -100.0%
ATRA -4,625 -26.0%
NGNE -4,615 -11.5%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 218,407 (9.7% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type